Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Texas Heart Institute Journal
|
May 9, 2014
Right ventricular sarcoidosis: is it time for updated diagnostic criteria?
Kairav Vakil, Elina Minami, Daniel P Fishbein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2007
Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients
Fanny Li, Kenneth W Kenyon, Katharine A Kirby, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
May 9, 2006
Expectant management is safe for cholelithiasis after heart transplant
Hiroo Takeyama, Mika N Sinanan, Daniel P Fishbein, et al.
Texas Heart Institute Journal
|
October 17, 2006
Open-chest management after heart transplantation
Hiroo Takayama, Richard J Leone, Gabriel S Aldea, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
February 3, 2007
Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation?
Hiroo Takayama, Avery B Nathens, Heather Merry, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 6, 2020
Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high-risk donor seropositive/recipient seronegative heart transplant recipients
Hannah Imlay, Allison O Dumitriu Carcoana, Cynthia E Fisher, et al.
Journal of the American College of Cardiology
|
April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
The American Journal of Cardiology
|
June 14, 2005
Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure
Kier V Huehnergarth, Dariush Mozaffarian, Mark D Sullivan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 19, 2010
Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement
Eric S Ketchum, Alec J Moorman, Daniel P Fishbein, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 19, 2022
TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
Barry H Trachtenberg, Javier Jimenez, Alanna A Morris, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Texas Heart Institute Journal
|
May 9, 2014
Right ventricular sarcoidosis: is it time for updated diagnostic criteria?
Kairav Vakil, Elina Minami, Daniel P Fishbein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2007
Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients
Fanny Li, Kenneth W Kenyon, Katharine A Kirby, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
May 9, 2006
Expectant management is safe for cholelithiasis after heart transplant
Hiroo Takeyama, Mika N Sinanan, Daniel P Fishbein, et al.
Texas Heart Institute Journal
|
October 17, 2006
Open-chest management after heart transplantation
Hiroo Takayama, Richard J Leone, Gabriel S Aldea, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
February 3, 2007
Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation?
Hiroo Takayama, Avery B Nathens, Heather Merry, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 6, 2020
Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high-risk donor seropositive/recipient seronegative heart transplant recipients
Hannah Imlay, Allison O Dumitriu Carcoana, Cynthia E Fisher, et al.
Journal of the American College of Cardiology
|
April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
The American Journal of Cardiology
|
June 14, 2005
Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure
Kier V Huehnergarth, Dariush Mozaffarian, Mark D Sullivan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 19, 2010
Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement
Eric S Ketchum, Alec J Moorman, Daniel P Fishbein, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 19, 2022
TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
Barry H Trachtenberg, Javier Jimenez, Alanna A Morris, et al.
Page
of 3